Numerous studies in humans, animal models and cell lines have suggested the potential benefits from the consumption
of green tea polyphenols, including prevention of cancer and heart diseases. However these potential effects
have been strongly limited by green tea catechins low bioavailability, which hinders the development of therapeutic applications.
In this review formulations that are being proposed for delivery of green tea catechins are discussed. New delivery
systems are presented as valid alternatives to overcome the limitations such as green tea catechins poor stability or intestinal
Keywords: Antioxidant, drug delivery, epigallocatechin-3-gallate, green tea polyphenols, catechins, EGCG.
Rights & PermissionsPrintExport
Published on: 19 November, 2013
Page: [4744 - 4757]